Star Combo Pharma Limited (ASX: S66) announced that it has entered into an agreement to acquire 51% of Australian Inature Organic Care Pty Limited (Inature) under which it will be able to access new consumer health products in the pre-natal, post-natal and infant markets:
- Inature will bring a team of sales and marketing workforce and networks that S66 can use for its full brand portfolio.
- Presently, Inature’s products are available via a set distribution network of 3,000 retail outlets in China.
- Under the agreement, S66 will manufacture Inature’s consumer health products in its manufacturing facilities in Sydney.
At AEST 1:55 PM, S66 quoted $0.480, down by 7.6%.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.